With a PhD in Inorganic Biochemistry, Kate joins the team from international healthcare consultancy Chameleon Communications, where she worked across publications and medical communications. Kate is experienced in a wide range of therapy areas, including immunology, specifically Crohn’s disease, ulcerative colitis and psoriatic arthritis, in ophthalmology, including retinal diseases, glaucoma and dry eye disease, in rare diseases such as Gaucher disease and Cushing’s disease and in hepatitis C. She also has experience in cardiovascular disease, haematology and infectious diseases.
Talia studied Human Biology at the University of Birmingham with a focus on Medical Pathways, followed by a Masters in Forensic Medical Sciences at Barts and The London School of Medicine and Dentistry.
Gill Boucher, Medical Director at emotive commented “We are delighted that Kate and Talia have joined the team. Kate’s wealth of experience is a great addition to our existing capabilities in scientific communications and medical education, and Talia’s strong scientific background will help us continue to excel at developing compelling narratives and engaging activities. At emotive, developing the right team is key to our continued delivery of strategic communications advice and high quality medical communications.”
emotive is an award-winning healthcare communications agency working with leading global life sciences companies including medical device and rare disease specialists.
We believe that only true engagement can drive genuine behaviour change. Our combination of scientific, creative and technical expertise stimulates the optimal participation of HCPs, people living with a disease, and other stakeholders in the care pathway. For emotive, engagement is everything.
To learn more about how we drive engagement with healthcare stakeholders, email Chris Edmonds on chris@thinkemotive.com or call +44 (0) 207 148 0408